Programming electronic systems is easier than ever. MicroPython makes it simple to program affordable MCUs, from the ...

Het programmeren van kleine elektronische systemen is eenvoudiger dan ooit. MicroPython maakt het eenvoudig om betaalbare microcontrollers te programmeren, van de Raspberry Pi Pico tot ESP32-boards ...

Replimune (REPL) has announced that it has no other option but to reduce its workforce and scale back U.S. manufacturing operations after the FDA on Friday declined to approve its lead asset, RP1, ...

FDA has now rejected Replimune’s melanoma immunotherapy RP1 on two separate occasions The drug was under consideration for use with Bristol Myers Squibb’s (BMY) Opdivo therapy Regulators maintained ...

Explore practical examples of handling long-context inputs and using REPL for testing and iterating. Understand how these tools improve accuracy and workflow in AI systems. Social Security cuts ...

See how new updates to computer‑using agents improve UI automation with secure credentials, detailed monitoring, and scalable Cloud PC capacity. When we first introduced computer-using agents ...

The percentage of teachers who are using artificial intelligence-driven tools in their classrooms nearly doubled between 2023 and 2025, according to data from the EdWeek Research Center. In 2023, a ...

Send a note to Doug Wintemute, Kara Coleman Fields and our other editors. We read every email. By submitting this form, you agree to allow us to collect, store, and potentially publish your provided ...

To better understand which social media platforms Americans use, Pew Research Center surveyed 5,022 U.S. adults from Feb. 5 to June 18, 2025. SSRS conducted this National Public Opinion Reference ...

FDA accepted Replimune’s resubmitted Biologics License Application for RP1 combined with Bristol Myers Squibb’s Opdivo to treat advanced melanoma The agency set April 10, 2026 as the decision deadline ...